登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
C6H5OP(O)Cl2
化学文摘社编号:
分子量:
210.98
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
212-220-6
Beilstein/REAXYS Number:
511863
MDL number:
Assay:
≥95%
产品名称
二氯磷酸苯酯, ≥95%
InChI key
TXFOLHZMICYNRM-UHFFFAOYSA-N
InChI
1S/C6H5Cl2O2P/c7-11(8,9)10-6-4-2-1-3-5-6/h1-5H
SMILES string
ClP(Cl)(=O)Oc1ccccc1
assay
≥95%
refractive index
n20/D 1.523 (lit.)
bp
241-243 °C (lit.)
density
1.412 g/mL at 25 °C (lit.)
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
用于制备磷酸二酯。
signalword
Danger
hcodes
Hazard Classifications
Skin Corr. 1B
存储类别
8A - Combustible corrosive hazardous materials
wgk
WGK 3
flash_point_f
235.4 °F - closed cup
flash_point_c
113 °C - closed cup
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Chun-Wei Kuo et al.
Molecules (Basel, Switzerland), 17(11), 13662-13672 (2012-11-22)
Upon treatment with phenyl dichlorophosphate (PhOP=OCl(2)) in acetonitrile at ambient temperature, a variety of ketoximes underwent a Beckmann rearrangement in an effective manner to afford the corresponding amides in moderate to high yields.
The Journal of Organic Chemistry, 53, 2077-2077 (1988)
Xiaoming Zhou et al.
Chemosphere, 235, 163-168 (2019-07-01)
Two novel phosphorus-containing copolyesters were synthesized by direct polycondensation reaction of phenyl dichlorophosphate, 1,4-succinic acid and 1,4-butanediol using stannous chloride (SnCl2) and 4-Methylbenzenesulfonic acid as catalyst, and its chemical structures were identified by 1H and 31P nuclear magnetic resonances (1H
Yvan Ecochard et al.
Molecules (Basel, Switzerland), 24(9) (2019-05-15)
Epoxy materials have attracted attention for many applications that require fireproof performance; however, the utilization of hazardous reagents brings about potential damage to human health. Eugenol and cardanol are renewable, harmless resources (according to ECHA) that allow the achievement of
Dhruvkumar Soni et al.
Biomaterials, 222, 119441-119441 (2019-09-01)
While antiretroviral therapy (ART) has revolutionized treatment and prevention of human immunodeficiency virus type one (HIV-1) infection, regimen adherence, viral mutations, drug toxicities and access stigma and fatigue are treatment limitations. These have led to new opportunities for the development
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持